TAMPA: Utterback named CEO at Moffitt's M2Gen subsidiary
Moffitt Cancer Center, November 30, 2009
James Utterback has been named CEO of M2Gen, a wholly owned for-profit subsidiary of Moffitt Cancer Center, effective Dec. 7. Utterback will be responsible for developing and implementing effective growth strategies, determining commercialization opportunities, and establishing and executing pharmaceutical company-funded clinical trials.
Most Viewed
Most Emailed
- Patient Harm Data to Remain on Medicare's Hospital Compare Site
- Quiet ORs Better for Patient Safety
- Tavenner Confirmed as CMS Administrator
- Leapfrog Hospital Safety Scores 'Depressing'
- Building a Better Healthcare Board
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Hard-Nosed About Physician Teamwork
- Healthcare Leaders Sound Off on Organized Labor
- Case Study: Advance Care Conversations
- Esther Dyson's Population Health Dream
